Institutional investors purchased a net $790.4 thousand shares of MNOV during the quarter ended March 2016, and now own 18.20% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 462.3 Thousand shares of MediciNova Inc